Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing

19 May 2020

Abstract excerpt

The quest for the effective treatment against coronavirus disease 2019 pneumonia caused by the severe acute respiratory syndrome (SARS)-coronavirus 2(CoV-2) coronavirus is hampered by the lack of knowledge concerning the basic cell biology of the infection. Given that most viruses use endocytosis to enter the host cell, mechanistic investigation of SARS-CoV-2 infection needs to consider the diversity of endocytic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cellular transport and secretion
Share to Lipid Membrane Structure and Behavior
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32428379
DOI: 10.1111/febs.15369

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposingPMID 32428379Read ↗

Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactomeSemantic proximity Read ↗

Pharmacological perturbation of intracellular dynamics as a SARS-CoV-2 antiviral strategySemantic proximity Read ↗

Inhibitors of SARS-CoV‑2 Entry: Current and Future OpportunitiesSemantic proximity Read ↗

A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanismSemantic proximity Read ↗

Endocytosis Inhibitors Block SARS-CoV-2 Pseudoparticle Infection of Mink Lung EpitheliumSemantic proximity Read ↗

Human TMPRSS2 non-catalytic ectodomain and SARS-CoV-2 S2’ subunit interaction mediated SARS-CoV-2 endocytosis: A model proposal with virtual screening for potential drug molecules to inhibit this interactionSemantic proximity Read ↗

Entrectinib - a SARS-CoV-2 inhibitor in Human Lung Tissue (HLT) cellsSemantic proximity Read ↗

Platycodin D prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection <i>in vitro</i> by hindering membrane fusionSemantic proximity Read ↗

A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entrySemantic proximity Read ↗

Single-virus fusion measurements reveal multiple mechanistically equivalent pathways for SARS-CoV-2 entrySemantic proximity Read ↗

Structural and dynamical analysis of integrated human/SARS-CoV-2 metabolic models present novel treatment strategies against COVID-19Semantic proximity Read ↗

Dual inhibition of vacuolar ATPase and TMPRSS2 is required for complete blockade of SARS-CoV-2 entry into cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.